Elanco
David Pugh currently serves as the Chief Financial Officer at AgReliant Genetics, LLC since August 2023. Prior to this role, David Pugh held multiple positions at Elanco starting in August 2018, including VP of Finance/Treasurer and Corporate Treasurer/Senior Director of Financial Strategy. David Pugh's extensive experience at Eli Lilly and Company spanned from October 1994 to July 2018, where roles included Executive Advisor for Corporate Strategy, Executive Director of Diabetes Finance, and CFO for Russia/CIS, overseeing various financial operations. Additionally, David Pugh's early career included positions in corporate financial planning and analysis as well as programming at Lexmark. David Pugh holds an MBA in Finance from Indiana University Indianapolis and a BS in Computer Science from Purdue University.
Elanco
26 followers
Elanco Animal Health Incorporated is an animal health company that develops, manufactures and markets products for companion and food animals. The Company offers its products under four primary categories, such as Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine.